1. Home
  2. COEP vs ISRL Comparison

COEP vs ISRL Comparison

Compare COEP & ISRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ISRL
  • Stock Information
  • Founded
  • COEP 2017
  • ISRL 2021
  • Country
  • COEP United States
  • ISRL United States
  • Employees
  • COEP N/A
  • ISRL N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ISRL Blank Checks
  • Sector
  • COEP Health Care
  • ISRL Finance
  • Exchange
  • COEP Nasdaq
  • ISRL Nasdaq
  • Market Cap
  • COEP 86.0M
  • ISRL 80.2M
  • IPO Year
  • COEP N/A
  • ISRL 2023
  • Fundamental
  • Price
  • COEP $16.95
  • ISRL $12.35
  • Analyst Decision
  • COEP
  • ISRL
  • Analyst Count
  • COEP 0
  • ISRL 0
  • Target Price
  • COEP N/A
  • ISRL N/A
  • AVG Volume (30 Days)
  • COEP 63.6K
  • ISRL 2.4K
  • Earning Date
  • COEP 11-12-2025
  • ISRL 01-01-0001
  • Dividend Yield
  • COEP N/A
  • ISRL N/A
  • EPS Growth
  • COEP N/A
  • ISRL N/A
  • EPS
  • COEP N/A
  • ISRL 0.14
  • Revenue
  • COEP $263,555.00
  • ISRL N/A
  • Revenue This Year
  • COEP N/A
  • ISRL N/A
  • Revenue Next Year
  • COEP N/A
  • ISRL N/A
  • P/E Ratio
  • COEP N/A
  • ISRL $93.89
  • Revenue Growth
  • COEP N/A
  • ISRL N/A
  • 52 Week Low
  • COEP $2.31
  • ISRL $11.14
  • 52 Week High
  • COEP $19.19
  • ISRL $14.00
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.29
  • ISRL 46.77
  • Support Level
  • COEP $16.00
  • ISRL $12.30
  • Resistance Level
  • COEP $18.15
  • ISRL $13.00
  • Average True Range (ATR)
  • COEP 1.60
  • ISRL 0.29
  • MACD
  • COEP 0.06
  • ISRL 0.01
  • Stochastic Oscillator
  • COEP 63.31
  • ISRL 31.67

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ISRL Israel Acquisitions Corp

Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: